Application no. and date | 08732358.0 (espacenet) (Federated) (European Patent Register), 20080317 | Patent/reg. no. and date | DK/EP 2136633, 20151028 | Publication date | 20091230 | Priority no. and date | US 894932 P, 20070315 | EP pub. no. and date |
EP 2136633 20091230 | Effective date | | Applicant/owner | SillaJen Biotherapeutics, Inc., 450 Sansome Street, Suite 650
San Francisco, CA 94111, US | Applicant ref. no. | P81505084DK00E | Inventor | KIRN, David, 444 La Verne Ave.
Mill Valley, CA 64941, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A01N 43/04 (2006.01) , A01N 63/00 (2006.01) , A61K 31/70 (2006.01) , A61K 48/00 (2006.01) | Title | Cancerterapi med onkolytisk vacciniavirus | Int. application no. | US2008057257 | Int. publication no. | WO2008113078 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|